Pharma & Healthcare
Global Adapalene Drugs Market Research Report 2026
- Feb 03, 26
- ID: 699645
- Pages: 119
- Figures: 119
- Views: 8
This report delivers a comprehensive overview of the global Adapalene Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adapalene Drugs. The Adapalene Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Adapalene Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adapalene Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sandoz
Galderma
Bausch Health
Glenmark
Encube Ethicals
Actavis
Taro Pharmaceutical
Alembic
Heilongjiang Fuhe Pharmaceutical
HEC Pharm
Sichuan Med-Shine Pharmaceutical
Wuhan Nuoan Pharmaceutical
Jiangsu Fubang Pharmaceutical
Beijing Foyou Pharmaceutical
Segment by Type
Cream
Solution
Gel
Others
by Application
Acne
Keratosis Pilaris
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Adapalene Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Adapalene Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Adapalene Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adapalene Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sandoz
Galderma
Bausch Health
Glenmark
Encube Ethicals
Actavis
Taro Pharmaceutical
Alembic
Heilongjiang Fuhe Pharmaceutical
HEC Pharm
Sichuan Med-Shine Pharmaceutical
Wuhan Nuoan Pharmaceutical
Jiangsu Fubang Pharmaceutical
Beijing Foyou Pharmaceutical
Segment by Type
Cream
Solution
Gel
Others
by Application
Acne
Keratosis Pilaris
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Adapalene Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Adapalene Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Adapalene Drugs Market Overview
1.1 Product Definition
1.2 Adapalene Drugs by Type
1.2.1 Global Adapalene Drugs Market Value by Type: 2025 vs 2032
1.2.2 Cream
1.2.3 Solution
1.2.4 Gel
1.2.5 Others
1.3 Adapalene Drugs by Application
1.3.1 Global Adapalene Drugs Market Value by Application: 2025 vs 2032
1.3.2 Acne
1.3.3 Keratosis Pilaris
1.3.4 Others
1.4 Global Adapalene Drugs Market Size Estimates and Forecasts
1.4.1 Global Adapalene Drugs Revenue 2021–2032
1.4.2 Global Adapalene Drugs Sales 2021–2032
1.4.3 Global Adapalene Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Adapalene Drugs Market Competition by Manufacturers
2.1 Global Adapalene Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Adapalene Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Adapalene Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Adapalene Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Adapalene Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Adapalene Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Adapalene Drugs, Date of Entry into the Industry
2.8 Global Adapalene Drugs Market Competitive Situation and Trends
2.8.1 Global Adapalene Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Adapalene Drugs Players Market Share by Revenue
2.8.3 Global Adapalene Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adapalene Drugs Market Scenario by Region
3.1 Global Adapalene Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Adapalene Drugs Sales by Region: 2021–2032
3.2.1 Global Adapalene Drugs Sales by Region: 2021–2026
3.2.2 Global Adapalene Drugs Sales by Region: 2027–2032
3.3 Global Adapalene Drugs Revenue by Region: 2021–2032
3.3.1 Global Adapalene Drugs Revenue by Region: 2021–2026
3.3.2 Global Adapalene Drugs Revenue by Region: 2027–2032
3.4 North America Adapalene Drugs Market Facts & Figures by Country
3.4.1 North America Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Adapalene Drugs Sales by Country (2021–2032)
3.4.3 North America Adapalene Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adapalene Drugs Market Facts & Figures by Country
3.5.1 Europe Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Adapalene Drugs Sales by Country (2021–2032)
3.5.3 Europe Adapalene Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adapalene Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Adapalene Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Adapalene Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Adapalene Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adapalene Drugs Market Facts & Figures by Country
3.7.1 Latin America Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Adapalene Drugs Sales by Country (2021–2032)
3.7.3 Latin America Adapalene Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adapalene Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Adapalene Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Adapalene Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adapalene Drugs Sales by Type (2021–2032)
4.1.1 Global Adapalene Drugs Sales by Type (2021–2026)
4.1.2 Global Adapalene Drugs Sales by Type (2027–2032)
4.1.3 Global Adapalene Drugs Sales Market Share by Type (2021–2032)
4.2 Global Adapalene Drugs Revenue by Type (2021–2032)
4.2.1 Global Adapalene Drugs Revenue by Type (2021–2026)
4.2.2 Global Adapalene Drugs Revenue by Type (2027–2032)
4.2.3 Global Adapalene Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Adapalene Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Adapalene Drugs Sales by Application (2021–2032)
5.1.1 Global Adapalene Drugs Sales by Application (2021–2026)
5.1.2 Global Adapalene Drugs Sales by Application (2027–2032)
5.1.3 Global Adapalene Drugs Sales Market Share by Application (2021–2032)
5.2 Global Adapalene Drugs Revenue by Application (2021–2032)
5.2.1 Global Adapalene Drugs Revenue by Application (2021–2026)
5.2.2 Global Adapalene Drugs Revenue by Application (2027–2032)
5.2.3 Global Adapalene Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Adapalene Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sandoz
6.1.1 Sandoz Company Information
6.1.2 Sandoz Description and Business Overview
6.1.3 Sandoz Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sandoz Adapalene Drugs Product Portfolio
6.1.5 Sandoz Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Company Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Galderma Adapalene Drugs Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Company Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bausch Health Adapalene Drugs Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Glenmark
6.4.1 Glenmark Company Information
6.4.2 Glenmark Description and Business Overview
6.4.3 Glenmark Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Glenmark Adapalene Drugs Product Portfolio
6.4.5 Glenmark Recent Developments/Updates
6.5 Encube Ethicals
6.5.1 Encube Ethicals Company Information
6.5.2 Encube Ethicals Description and Business Overview
6.5.3 Encube Ethicals Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Encube Ethicals Adapalene Drugs Product Portfolio
6.5.5 Encube Ethicals Recent Developments/Updates
6.6 Actavis
6.6.1 Actavis Company Information
6.6.2 Actavis Description and Business Overview
6.6.3 Actavis Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Actavis Adapalene Drugs Product Portfolio
6.6.5 Actavis Recent Developments/Updates
6.7 Taro Pharmaceutical
6.7.1 Taro Pharmaceutical Company Information
6.7.2 Taro Pharmaceutical Description and Business Overview
6.7.3 Taro Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Taro Pharmaceutical Adapalene Drugs Product Portfolio
6.7.5 Taro Pharmaceutical Recent Developments/Updates
6.8 Alembic
6.8.1 Alembic Company Information
6.8.2 Alembic Description and Business Overview
6.8.3 Alembic Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Alembic Adapalene Drugs Product Portfolio
6.8.5 Alembic Recent Developments/Updates
6.9 Heilongjiang Fuhe Pharmaceutical
6.9.1 Heilongjiang Fuhe Pharmaceutical Company Information
6.9.2 Heilongjiang Fuhe Pharmaceutical Description and Business Overview
6.9.3 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio
6.9.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
6.10 HEC Pharm
6.10.1 HEC Pharm Company Information
6.10.2 HEC Pharm Description and Business Overview
6.10.3 HEC Pharm Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 HEC Pharm Adapalene Drugs Product Portfolio
6.10.5 HEC Pharm Recent Developments/Updates
6.11 Sichuan Med-Shine Pharmaceutical
6.11.1 Sichuan Med-Shine Pharmaceutical Company Information
6.11.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.11.3 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio
6.11.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.12 Wuhan Nuoan Pharmaceutical
6.12.1 Wuhan Nuoan Pharmaceutical Company Information
6.12.2 Wuhan Nuoan Pharmaceutical Description and Business Overview
6.12.3 Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio
6.12.5 Wuhan Nuoan Pharmaceutical Recent Developments/Updates
6.13 Jiangsu Fubang Pharmaceutical
6.13.1 Jiangsu Fubang Pharmaceutical Company Information
6.13.2 Jiangsu Fubang Pharmaceutical Description and Business Overview
6.13.3 Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio
6.13.5 Jiangsu Fubang Pharmaceutical Recent Developments/Updates
6.14 Beijing Foyou Pharmaceutical
6.14.1 Beijing Foyou Pharmaceutical Company Information
6.14.2 Beijing Foyou Pharmaceutical Description and Business Overview
6.14.3 Beijing Foyou Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio
6.14.5 Beijing Foyou Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adapalene Drugs Industry Chain Analysis
7.2 Adapalene Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adapalene Drugs Production Mode & Process Analysis
7.4 Adapalene Drugs Sales and Marketing
7.4.1 Adapalene Drugs Sales Channels
7.4.2 Adapalene Drugs Distributors
7.5 Adapalene Drugs Customer Analysis
8 Adapalene Drugs Market Dynamics
8.1 Adapalene Drugs Industry Trends
8.2 Adapalene Drugs Market Drivers
8.3 Adapalene Drugs Market Challenges
8.4 Adapalene Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Adapalene Drugs by Type
1.2.1 Global Adapalene Drugs Market Value by Type: 2025 vs 2032
1.2.2 Cream
1.2.3 Solution
1.2.4 Gel
1.2.5 Others
1.3 Adapalene Drugs by Application
1.3.1 Global Adapalene Drugs Market Value by Application: 2025 vs 2032
1.3.2 Acne
1.3.3 Keratosis Pilaris
1.3.4 Others
1.4 Global Adapalene Drugs Market Size Estimates and Forecasts
1.4.1 Global Adapalene Drugs Revenue 2021–2032
1.4.2 Global Adapalene Drugs Sales 2021–2032
1.4.3 Global Adapalene Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Adapalene Drugs Market Competition by Manufacturers
2.1 Global Adapalene Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Adapalene Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Adapalene Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Adapalene Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Adapalene Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Adapalene Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Adapalene Drugs, Date of Entry into the Industry
2.8 Global Adapalene Drugs Market Competitive Situation and Trends
2.8.1 Global Adapalene Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Adapalene Drugs Players Market Share by Revenue
2.8.3 Global Adapalene Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adapalene Drugs Market Scenario by Region
3.1 Global Adapalene Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Adapalene Drugs Sales by Region: 2021–2032
3.2.1 Global Adapalene Drugs Sales by Region: 2021–2026
3.2.2 Global Adapalene Drugs Sales by Region: 2027–2032
3.3 Global Adapalene Drugs Revenue by Region: 2021–2032
3.3.1 Global Adapalene Drugs Revenue by Region: 2021–2026
3.3.2 Global Adapalene Drugs Revenue by Region: 2027–2032
3.4 North America Adapalene Drugs Market Facts & Figures by Country
3.4.1 North America Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Adapalene Drugs Sales by Country (2021–2032)
3.4.3 North America Adapalene Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adapalene Drugs Market Facts & Figures by Country
3.5.1 Europe Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Adapalene Drugs Sales by Country (2021–2032)
3.5.3 Europe Adapalene Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adapalene Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Adapalene Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Adapalene Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Adapalene Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adapalene Drugs Market Facts & Figures by Country
3.7.1 Latin America Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Adapalene Drugs Sales by Country (2021–2032)
3.7.3 Latin America Adapalene Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adapalene Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Adapalene Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Adapalene Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Adapalene Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adapalene Drugs Sales by Type (2021–2032)
4.1.1 Global Adapalene Drugs Sales by Type (2021–2026)
4.1.2 Global Adapalene Drugs Sales by Type (2027–2032)
4.1.3 Global Adapalene Drugs Sales Market Share by Type (2021–2032)
4.2 Global Adapalene Drugs Revenue by Type (2021–2032)
4.2.1 Global Adapalene Drugs Revenue by Type (2021–2026)
4.2.2 Global Adapalene Drugs Revenue by Type (2027–2032)
4.2.3 Global Adapalene Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Adapalene Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Adapalene Drugs Sales by Application (2021–2032)
5.1.1 Global Adapalene Drugs Sales by Application (2021–2026)
5.1.2 Global Adapalene Drugs Sales by Application (2027–2032)
5.1.3 Global Adapalene Drugs Sales Market Share by Application (2021–2032)
5.2 Global Adapalene Drugs Revenue by Application (2021–2032)
5.2.1 Global Adapalene Drugs Revenue by Application (2021–2026)
5.2.2 Global Adapalene Drugs Revenue by Application (2027–2032)
5.2.3 Global Adapalene Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Adapalene Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sandoz
6.1.1 Sandoz Company Information
6.1.2 Sandoz Description and Business Overview
6.1.3 Sandoz Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sandoz Adapalene Drugs Product Portfolio
6.1.5 Sandoz Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Company Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Galderma Adapalene Drugs Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Company Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bausch Health Adapalene Drugs Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Glenmark
6.4.1 Glenmark Company Information
6.4.2 Glenmark Description and Business Overview
6.4.3 Glenmark Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Glenmark Adapalene Drugs Product Portfolio
6.4.5 Glenmark Recent Developments/Updates
6.5 Encube Ethicals
6.5.1 Encube Ethicals Company Information
6.5.2 Encube Ethicals Description and Business Overview
6.5.3 Encube Ethicals Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Encube Ethicals Adapalene Drugs Product Portfolio
6.5.5 Encube Ethicals Recent Developments/Updates
6.6 Actavis
6.6.1 Actavis Company Information
6.6.2 Actavis Description and Business Overview
6.6.3 Actavis Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Actavis Adapalene Drugs Product Portfolio
6.6.5 Actavis Recent Developments/Updates
6.7 Taro Pharmaceutical
6.7.1 Taro Pharmaceutical Company Information
6.7.2 Taro Pharmaceutical Description and Business Overview
6.7.3 Taro Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Taro Pharmaceutical Adapalene Drugs Product Portfolio
6.7.5 Taro Pharmaceutical Recent Developments/Updates
6.8 Alembic
6.8.1 Alembic Company Information
6.8.2 Alembic Description and Business Overview
6.8.3 Alembic Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Alembic Adapalene Drugs Product Portfolio
6.8.5 Alembic Recent Developments/Updates
6.9 Heilongjiang Fuhe Pharmaceutical
6.9.1 Heilongjiang Fuhe Pharmaceutical Company Information
6.9.2 Heilongjiang Fuhe Pharmaceutical Description and Business Overview
6.9.3 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio
6.9.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
6.10 HEC Pharm
6.10.1 HEC Pharm Company Information
6.10.2 HEC Pharm Description and Business Overview
6.10.3 HEC Pharm Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 HEC Pharm Adapalene Drugs Product Portfolio
6.10.5 HEC Pharm Recent Developments/Updates
6.11 Sichuan Med-Shine Pharmaceutical
6.11.1 Sichuan Med-Shine Pharmaceutical Company Information
6.11.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.11.3 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio
6.11.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.12 Wuhan Nuoan Pharmaceutical
6.12.1 Wuhan Nuoan Pharmaceutical Company Information
6.12.2 Wuhan Nuoan Pharmaceutical Description and Business Overview
6.12.3 Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio
6.12.5 Wuhan Nuoan Pharmaceutical Recent Developments/Updates
6.13 Jiangsu Fubang Pharmaceutical
6.13.1 Jiangsu Fubang Pharmaceutical Company Information
6.13.2 Jiangsu Fubang Pharmaceutical Description and Business Overview
6.13.3 Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio
6.13.5 Jiangsu Fubang Pharmaceutical Recent Developments/Updates
6.14 Beijing Foyou Pharmaceutical
6.14.1 Beijing Foyou Pharmaceutical Company Information
6.14.2 Beijing Foyou Pharmaceutical Description and Business Overview
6.14.3 Beijing Foyou Pharmaceutical Adapalene Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio
6.14.5 Beijing Foyou Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adapalene Drugs Industry Chain Analysis
7.2 Adapalene Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adapalene Drugs Production Mode & Process Analysis
7.4 Adapalene Drugs Sales and Marketing
7.4.1 Adapalene Drugs Sales Channels
7.4.2 Adapalene Drugs Distributors
7.5 Adapalene Drugs Customer Analysis
8 Adapalene Drugs Market Dynamics
8.1 Adapalene Drugs Industry Trends
8.2 Adapalene Drugs Market Drivers
8.3 Adapalene Drugs Market Challenges
8.4 Adapalene Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Adapalene Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Adapalene Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Adapalene Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Adapalene Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Adapalene Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Adapalene Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Adapalene Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Adapalene Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Adapalene Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Adapalene Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Adapalene Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Adapalene Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adapalene Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adapalene Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adapalene Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Adapalene Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Adapalene Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Adapalene Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Adapalene Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Adapalene Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Adapalene Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Adapalene Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Adapalene Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Adapalene Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Adapalene Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Adapalene Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Adapalene Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Adapalene Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Adapalene Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Adapalene Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Adapalene Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Adapalene Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Adapalene Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Adapalene Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Adapalene Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Adapalene Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Adapalene Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Adapalene Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Adapalene Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Adapalene Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Adapalene Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Adapalene Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Adapalene Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Adapalene Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Adapalene Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Adapalene Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Adapalene Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Adapalene Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Sandoz Company Information
Table 71. Sandoz Description and Business Overview
Table 72. Sandoz Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sandoz Adapalene Drugs Product
Table 74. Sandoz Recent Developments/Updates
Table 75. Galderma Company Information
Table 76. Galderma Description and Business Overview
Table 77. Galderma Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Galderma Adapalene Drugs Product
Table 79. Galderma Recent Developments/Updates
Table 80. Bausch Health Company Information
Table 81. Bausch Health Description and Business Overview
Table 82. Bausch Health Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Bausch Health Adapalene Drugs Product
Table 84. Bausch Health Recent Developments/Updates
Table 85. Glenmark Company Information
Table 86. Glenmark Description and Business Overview
Table 87. Glenmark Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Glenmark Adapalene Drugs Product
Table 89. Glenmark Recent Developments/Updates
Table 90. Encube Ethicals Company Information
Table 91. Encube Ethicals Description and Business Overview
Table 92. Encube Ethicals Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Encube Ethicals Adapalene Drugs Product
Table 94. Encube Ethicals Recent Developments/Updates
Table 95. Actavis Company Information
Table 96. Actavis Description and Business Overview
Table 97. Actavis Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Actavis Adapalene Drugs Product
Table 99. Actavis Recent Developments/Updates
Table 100. Taro Pharmaceutical Company Information
Table 101. Taro Pharmaceutical Description and Business Overview
Table 102. Taro Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Taro Pharmaceutical Adapalene Drugs Product
Table 104. Taro Pharmaceutical Recent Developments/Updates
Table 105. Alembic Company Information
Table 106. Alembic Description and Business Overview
Table 107. Alembic Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Alembic Adapalene Drugs Product
Table 109. Alembic Recent Developments/Updates
Table 110. Heilongjiang Fuhe Pharmaceutical Company Information
Table 111. Heilongjiang Fuhe Pharmaceutical Description and Business Overview
Table 112. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product
Table 114. Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
Table 115. HEC Pharm Company Information
Table 116. HEC Pharm Description and Business Overview
Table 117. HEC Pharm Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. HEC Pharm Adapalene Drugs Product
Table 119. HEC Pharm Recent Developments/Updates
Table 120. Sichuan Med-Shine Pharmaceutical Company Information
Table 121. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 122. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product
Table 124. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 125. Wuhan Nuoan Pharmaceutical Company Information
Table 126. Wuhan Nuoan Pharmaceutical Description and Business Overview
Table 127. Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Wuhan Nuoan Pharmaceutical Adapalene Drugs Product
Table 129. Wuhan Nuoan Pharmaceutical Recent Developments/Updates
Table 130. Jiangsu Fubang Pharmaceutical Company Information
Table 131. Jiangsu Fubang Pharmaceutical Description and Business Overview
Table 132. Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Jiangsu Fubang Pharmaceutical Adapalene Drugs Product
Table 134. Jiangsu Fubang Pharmaceutical Recent Developments/Updates
Table 135. Beijing Foyou Pharmaceutical Company Information
Table 136. Beijing Foyou Pharmaceutical Description and Business Overview
Table 137. Beijing Foyou Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Beijing Foyou Pharmaceutical Adapalene Drugs Product
Table 139. Beijing Foyou Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Adapalene Drugs Distributors List
Table 143. Adapalene Drugs Customers List
Table 144. Adapalene Drugs Market Trends
Table 145. Adapalene Drugs Market Drivers
Table 146. Adapalene Drugs Market Challenges
Table 147. Adapalene Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adapalene Drugs
Figure 2. Global Adapalene Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Adapalene Drugs Market Share by Type: 2025 & 2032
Figure 4. Cream Product Picture
Figure 5. Solution Product Picture
Figure 6. Gel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Adapalene Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Adapalene Drugs Market Share by Application: 2025 & 2032
Figure 10. Acne
Figure 11. Keratosis Pilaris
Figure 12. Others
Figure 13. Global Adapalene Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Adapalene Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Adapalene Drugs Sales (K Units), 2021–2032
Figure 16. Global Adapalene Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Adapalene Drugs Report Years Considered
Figure 18. Adapalene Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Adapalene Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Adapalene Drugs Players: Market Share by Revenue in Adapalene Drugs in 2025
Figure 21. Adapalene Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Adapalene Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Adapalene Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Adapalene Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Adapalene Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Adapalene Drugs by Type (2021–2032)
Figure 56. Global Adapalene Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Adapalene Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Adapalene Drugs by Application (2021–2032)
Figure 59. Global Adapalene Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Adapalene Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Adapalene Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Adapalene Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Adapalene Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Adapalene Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Adapalene Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Adapalene Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Adapalene Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Adapalene Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Adapalene Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Adapalene Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Adapalene Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Adapalene Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adapalene Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adapalene Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adapalene Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Adapalene Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Adapalene Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Adapalene Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Adapalene Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Adapalene Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Adapalene Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Adapalene Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Adapalene Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Adapalene Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Adapalene Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Adapalene Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Adapalene Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Adapalene Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Adapalene Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Adapalene Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Adapalene Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Adapalene Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Adapalene Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Adapalene Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Adapalene Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Adapalene Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Adapalene Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Adapalene Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Adapalene Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Adapalene Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Adapalene Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Adapalene Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Adapalene Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Adapalene Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Adapalene Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Adapalene Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Adapalene Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Adapalene Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Adapalene Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Adapalene Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Adapalene Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Adapalene Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Adapalene Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Sandoz Company Information
Table 71. Sandoz Description and Business Overview
Table 72. Sandoz Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sandoz Adapalene Drugs Product
Table 74. Sandoz Recent Developments/Updates
Table 75. Galderma Company Information
Table 76. Galderma Description and Business Overview
Table 77. Galderma Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Galderma Adapalene Drugs Product
Table 79. Galderma Recent Developments/Updates
Table 80. Bausch Health Company Information
Table 81. Bausch Health Description and Business Overview
Table 82. Bausch Health Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Bausch Health Adapalene Drugs Product
Table 84. Bausch Health Recent Developments/Updates
Table 85. Glenmark Company Information
Table 86. Glenmark Description and Business Overview
Table 87. Glenmark Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Glenmark Adapalene Drugs Product
Table 89. Glenmark Recent Developments/Updates
Table 90. Encube Ethicals Company Information
Table 91. Encube Ethicals Description and Business Overview
Table 92. Encube Ethicals Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Encube Ethicals Adapalene Drugs Product
Table 94. Encube Ethicals Recent Developments/Updates
Table 95. Actavis Company Information
Table 96. Actavis Description and Business Overview
Table 97. Actavis Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Actavis Adapalene Drugs Product
Table 99. Actavis Recent Developments/Updates
Table 100. Taro Pharmaceutical Company Information
Table 101. Taro Pharmaceutical Description and Business Overview
Table 102. Taro Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Taro Pharmaceutical Adapalene Drugs Product
Table 104. Taro Pharmaceutical Recent Developments/Updates
Table 105. Alembic Company Information
Table 106. Alembic Description and Business Overview
Table 107. Alembic Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Alembic Adapalene Drugs Product
Table 109. Alembic Recent Developments/Updates
Table 110. Heilongjiang Fuhe Pharmaceutical Company Information
Table 111. Heilongjiang Fuhe Pharmaceutical Description and Business Overview
Table 112. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product
Table 114. Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
Table 115. HEC Pharm Company Information
Table 116. HEC Pharm Description and Business Overview
Table 117. HEC Pharm Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. HEC Pharm Adapalene Drugs Product
Table 119. HEC Pharm Recent Developments/Updates
Table 120. Sichuan Med-Shine Pharmaceutical Company Information
Table 121. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 122. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product
Table 124. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 125. Wuhan Nuoan Pharmaceutical Company Information
Table 126. Wuhan Nuoan Pharmaceutical Description and Business Overview
Table 127. Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Wuhan Nuoan Pharmaceutical Adapalene Drugs Product
Table 129. Wuhan Nuoan Pharmaceutical Recent Developments/Updates
Table 130. Jiangsu Fubang Pharmaceutical Company Information
Table 131. Jiangsu Fubang Pharmaceutical Description and Business Overview
Table 132. Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Jiangsu Fubang Pharmaceutical Adapalene Drugs Product
Table 134. Jiangsu Fubang Pharmaceutical Recent Developments/Updates
Table 135. Beijing Foyou Pharmaceutical Company Information
Table 136. Beijing Foyou Pharmaceutical Description and Business Overview
Table 137. Beijing Foyou Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Beijing Foyou Pharmaceutical Adapalene Drugs Product
Table 139. Beijing Foyou Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Adapalene Drugs Distributors List
Table 143. Adapalene Drugs Customers List
Table 144. Adapalene Drugs Market Trends
Table 145. Adapalene Drugs Market Drivers
Table 146. Adapalene Drugs Market Challenges
Table 147. Adapalene Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adapalene Drugs
Figure 2. Global Adapalene Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Adapalene Drugs Market Share by Type: 2025 & 2032
Figure 4. Cream Product Picture
Figure 5. Solution Product Picture
Figure 6. Gel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Adapalene Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Adapalene Drugs Market Share by Application: 2025 & 2032
Figure 10. Acne
Figure 11. Keratosis Pilaris
Figure 12. Others
Figure 13. Global Adapalene Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Adapalene Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Adapalene Drugs Sales (K Units), 2021–2032
Figure 16. Global Adapalene Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Adapalene Drugs Report Years Considered
Figure 18. Adapalene Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Adapalene Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Adapalene Drugs Players: Market Share by Revenue in Adapalene Drugs in 2025
Figure 21. Adapalene Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Adapalene Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Adapalene Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Adapalene Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Adapalene Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Adapalene Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Adapalene Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Adapalene Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Adapalene Drugs by Type (2021–2032)
Figure 56. Global Adapalene Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Adapalene Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Adapalene Drugs by Application (2021–2032)
Figure 59. Global Adapalene Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Adapalene Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232